AFLIBERCEPT IN COMBINATION WITH DOCETAXEL FOR SECOND-LINE TREATMENT OF LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER (NSCLC): FINAL RESULTS OF A MULTINATIONAL PLACEBO-CONTROLLED PHASE III TRIAL (EFC10261-VITAL)
dc.contributor.author | Novello, Silvia | |
dc.contributor.author | Ramlau, Rodryg | |
dc.contributor.author | Gorbunova, Vera A. | |
dc.contributor.author | Ciuleanu, Tudor E. | |
dc.contributor.author | Ozguroglu, Mustafa | |
dc.contributor.author | Goksel, Tuncay | |
dc.contributor.author | Baldotto, Clarissa | |
dc.contributor.author | Bennouna, Jaafar | |
dc.contributor.author | Shepherd, Frances A. | |
dc.contributor.author | Scagliotti, Giorgio | |
dc.date.accessioned | 2019-10-27T21:24:11Z | |
dc.date.available | 2019-10-27T21:24:11Z | |
dc.date.issued | 2011 | |
dc.department | Ege Üniversitesi | en_US |
dc.identifier.endpage | S470 | en_US |
dc.identifier.issn | 1556-0864 | |
dc.identifier.issn | 1556-1380 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.startpage | S470 | en_US |
dc.identifier.uri | https://hdl.handle.net/11454/44420 | |
dc.identifier.volume | 6 | en_US |
dc.identifier.wos | WOS:000208855802199 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartof | Journal of Thoracic Oncology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Angiogenesis inhibitors | en_US |
dc.subject | Vascular endothelial growth factor (VEGF) | en_US |
dc.subject | Phase III clinical trials | en_US |
dc.title | AFLIBERCEPT IN COMBINATION WITH DOCETAXEL FOR SECOND-LINE TREATMENT OF LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER (NSCLC): FINAL RESULTS OF A MULTINATIONAL PLACEBO-CONTROLLED PHASE III TRIAL (EFC10261-VITAL) | en_US |
dc.type | Conference Object | en_US |